glucuronic acid has been researched along with Breast Cancer in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (4.17) | 29.6817 |
2010's | 21 (87.50) | 24.3611 |
2020's | 2 (8.33) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Ding, S; Liu, S; Peng, Y; Zheng, J | 1 |
Bhura, N; Gupta, J; Gupta, P | 1 |
Bunnell, BA; Burow, ME; Chrisey, DB; Huang, Y; Murfee, WL; Phamduy, TB; Riggs, B; Shipman, J; Sklare, SC; Strong, AL; Vinson, BT | 1 |
Baghbani, F; Chegeni, M; Mohandesi, JA; Mokhtari-Dizaji, M; Moztarzadeh, F | 1 |
Li, F; Shen, H; Wang, D; Wang, X; Yang, Z; Yao, C; Ye, Y | 1 |
Webster, TJ; Zhang, L | 1 |
Gopta, EV; Korotina, MA; Korytov, OV; Korytova, LI; Masliukova, EA; Oltarzhevskaia, ND | 1 |
Blanco, MD; Iglesias, I; Martínez, A; Muñiz, E; Teijón, C; Teijón, JM | 1 |
Akbari Javar, H; Farjam, AS; Ibrahim Noordin, M; Kadivar, A; Kamalidehghan, B; Taghizadeh Davoudi, E | 1 |
Aizenberg, M; Brudno, Y; Kearney, CJ; Lewin, SA; Martinick, KD; Miller, A; Mooney, DJ; Silva, EA | 1 |
Grolman, JM; Kilian, KA; Moore, JS; Smith, AM; Zhang, D | 1 |
Ng, SF; Tan, SL | 1 |
Ismail, H; Martien, R; Name, S; Wicaksono, PA | 1 |
Baghbani, F; Mohandesi, JA; Mokhtari-Dizaji, M; Moztarzadeh, F; Yazdian, F | 1 |
Aliabadi, HS; Behdadfar, B; Hassanzadeh, F; Khoraskani, FR; Mirian, M; Varshosaz, J | 1 |
Beltrame, F; Cavo, M; Fato, M; Peñuela, L; Raiteri, R; Scaglione, S | 1 |
Brenner, E; Kasseroller, RG | 1 |
Bosman, F; Buchegger, F; Doelker, E; Faes, A; Hofmann, H; Jordan, O; Le Renard, PE; Petri-Fink, A; Rüfenacht, D | 1 |
Baggio, G; Bruni, E; Coppi, G; Iannuccelli, V; Rossi, T | 1 |
Chen, MC; Cheung, KC; Gupta, M | 1 |
Brulé, S; Gazeau, F; Le Visage, C; Letourneur, D; Levy, M; Ménager, C; Wilhelm, C | 1 |
Chen, JF; Tao, X; Teng, Y; Wang, LX; Wang, XL; Zeng, Y; Zheng, YZ | 1 |
Chen, X; Han, F; Li, Y; Tian, W; Yan, H; Yue, L; Zhang, Y; Zheng, H | 1 |
Ebiike, H; Kawada, H; Morikami, K; Nakamura, M; Ogawa, K; Ohwada, J; Shimma, N; Tsukazaki, M; Tsukuda, T; Yoshida, M; Yoshinari, K | 1 |
1 trial(s) available for glucuronic acid and Breast Cancer
Article | Year |
---|---|
A prospective randomised study of alginate-drenched low stretch bandages as an alternative to conventional lymphologic compression bandaging.
Topics: Adult; Aged; Aged, 80 and over; Alginates; Bandages, Hydrocolloid; Breast Neoplasms; Female; Glucuronic Acid; Hexuronic Acids; Humans; Lymphedema; Mastectomy, Modified Radical; Middle Aged; Prospective Studies; Treatment Outcome | 2010 |
23 other study(ies) available for glucuronic acid and Breast Cancer
Article | Year |
---|---|
Anastrozole and related glucuronic acid conjugate are electrophilic species.
Topics: Anastrozole; Animals; Breast Neoplasms; Chemical and Drug Induced Liver Injury; Female; Glucuronic Acid; Humans; Nitriles; Rats; Triazoles | 2022 |
Target-based in-silico screening of basil polysaccharides against different epigenetic targets responsible for breast cancer.
Topics: Breast Neoplasms; Early Detection of Cancer; Epigenesis, Genetic; Female; Galactose; Glucosamine; Glucose; Glucuronic Acid; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Mannose; Molecular Docking Simulation; Ocimum basilicum; Polysaccharides; Repressor Proteins; Rhamnose; Xylose | 2022 |
Laser direct-write based fabrication of a spatially-defined, biomimetic construct as a potential model for breast cancer cell invasion into adipose tissue.
Topics: Adipocytes; Alginates; Biomimetics; Bioprinting; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Coculture Techniques; Collagen; Computer-Aided Design; Epithelial-Mesenchymal Transition; Female; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogels; Lasers; MCF-7 Cells; Microscopy, Electron, Scanning; Models, Biological; Tissue Scaffolds | 2017 |
Ultrasonic nanotherapy of breast cancer using novel ultrasound-responsive alginate-shelled perfluorohexane nanodroplets: In vitro and in vivo evaluation.
Topics: Alginates; Breast Neoplasms; Doxorubicin; Drug Carriers; Fluorocarbons; Glucuronic Acid; Hexuronic Acids; Humans; Nanostructures; Tissue Distribution; Ultrasonics | 2017 |
Chitosan-alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer.
Topics: Alginates; Animals; Antineoplastic Agents; Breast Neoplasms; Capsules; Cell Line, Tumor; Cell Proliferation; Chitosan; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Gels; Glucuronic Acid; Hexuronic Acids; Humans; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Serum Albumin, Bovine; Structure-Activity Relationship | 2018 |
Effects of chemically modified nanostructured PLGA on functioning of lung and breast cancer cells.
Topics: Alginates; Analysis of Variance; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chitosan; Female; Glucuronic Acid; Hexuronic Acids; Humans; Lactic Acid; Lung Neoplasms; Nanostructures; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties | 2013 |
[Use of hydrogel tissues with 5-fluorouracil and sodium alginate, "COLETEX-5-FTUR," for radiomodification in cancer patients receiving radiation therapy].
Topics: Adult; Aged; Alginates; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorouracil; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Male; Middle Aged; Neoplasm Recurrence, Local; Rectal Neoplasms; Treatment Outcome | 2013 |
Targeting tamoxifen to breast cancer xenograft tumours: preclinical efficacy of folate-attached nanoparticles based on alginate-cysteine/disulphide-bond-reduced albumin.
Topics: Albumins; Alginates; Animals; Breast Neoplasms; Cysteine; Disulfides; Folic Acid; Glucuronic Acid; Hexuronic Acids; Humans; MCF-7 Cells; Mice; Mice, Nude; Nanoparticles; Tamoxifen; Xenograft Model Antitumor Assays | 2014 |
Preparation and characterization of a gastric floating dosage form of capecitabine.
Topics: Acrylic Resins; Alginates; Breast Neoplasms; Capecitabine; Chemistry, Pharmaceutical; Deoxycytidine; Drug Dosage Calculations; Female; Fluorouracil; Gastrointestinal Diseases; Glucuronic Acid; Hexuronic Acids; Humans; Hypromellose Derivatives; Methylcellulose; Sodium Bicarbonate; United States; United States Food and Drug Administration | 2013 |
Refilling drug delivery depots through the blood.
Topics: Alginates; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Disease Models, Animal; Doxorubicin; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; Humans; Hydrazones; Hydrogels; Injections, Intralesional; Injections, Intravenous; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Oligodeoxyribonucleotides; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
Rapid 3D Extrusion of Synthetic Tumor Microenvironments.
Topics: Adenocarcinoma; Alginates; Animals; Biomimetic Materials; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Coculture Techniques; Equipment Design; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogels; Lab-On-A-Chip Devices; Macrophages; Mice; Microfluidics; Tissue Scaffolds; Tumor Microenvironment | 2015 |
Development and in vitro assessment of alginate bilayer films containing the olive compound hydroxytyrosol as an alternative for topical chemotherapy.
Topics: Administration, Cutaneous; Alginates; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Survival; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Liberation; Female; Glucuronic Acid; Hexuronic Acids; Humans; MCF-7 Cells; Olea; Phenylethyl Alcohol; Rheology; Skin Neoplasms | 2015 |
Formulation and Cytotoxicity of Ribosome-Inactivating Protein Mirabilis Jalapa L. Nanoparticles Using Alginate-Low Viscosity Chitosan Conjugated with Anti-Epcam Antibodies in the T47D Breast Cancer Cell Line.
Topics: Alginates; Antibodies, Monoclonal; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Proliferation; Chemistry, Pharmaceutical; Chitosan; Epithelial Cell Adhesion Molecule; Female; Flow Cytometry; Glucuronic Acid; Hexuronic Acids; Humans; Mirabilis; Nanoparticles; Particle Size; Plant Extracts; Plant Leaves; Ribosome Inactivating Proteins; Tumor Cells, Cultured; Viscosity | 2016 |
Novel alginate-stabilized doxorubicin-loaded nanodroplets for ultrasounic theranosis of breast cancer.
Topics: Alginates; Animals; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Carriers; Female; Glucuronic Acid; Hexuronic Acids; Humans; Mice; Mice, Inbred BALB C; Nanoparticles; Theranostic Nanomedicine; Xenograft Model Antitumor Assays | 2016 |
Targeted delivery of doxorubicin to breast cancer cells by magnetic LHRH chitosan bioconjugated nanoparticles.
Topics: Alginates; Breast Neoplasms; Chitosan; Doxorubicin; Drug Carriers; Ferric Compounds; Glucuronic Acid; Gonadotropin-Releasing Hormone; Hexuronic Acids; Humans; Maleates; MCF-7 Cells; Nanoparticles; Particle Size; Polyethylenes | 2016 |
Microenvironment complexity and matrix stiffness regulate breast cancer cell activity in a 3D in vitro model.
Topics: Adenocarcinoma; Alginates; Breast Neoplasms; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Lineage; Cell Proliferation; Cell Survival; Cluster Analysis; Elastic Modulus; Elasticity; Female; Flow Cytometry; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogels; In Vitro Techniques; MCF-7 Cells; Microscopy, Atomic Force; Pressure; Tissue Engineering; Tumor Microenvironment | 2016 |
The in vivo performance of magnetic particle-loaded injectable, in situ gelling, carriers for the delivery of local hyperthermia.
Topics: Alginates; Animals; Breast Neoplasms; Chitosan; Female; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogels; Hyperthermia, Induced; Magnetics; Mice; Mice, Nude; Mice, SCID; Nanoparticles; Solvents; Transplantation, Heterologous | 2010 |
Role of the pharmaceutical excipients in the tamoxifen activity on MCF-7 and vero cell cultures.
Topics: Alginates; Animals; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Chitosan; Chlorocebus aethiops; Excipients; Glucuronic Acid; Hexuronic Acids; Humans; Particle Size; Tamoxifen; Vero Cells | 2009 |
Alginate-based microfluidic system for tumor spheroid formation and anticancer agent screening.
Topics: Alginates; Antineoplastic Agents; Breast Neoplasms; Cell Culture Techniques; Cell Death; Cell Proliferation; Cell Survival; Culture Media; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Drug Screening Assays, Antitumor; Glucuronic Acid; HeLa Cells; Hexuronic Acids; Humans; Hydrogels; Microfluidic Analytical Techniques; Spheroids, Cellular; Time Factors | 2010 |
Doxorubicin release triggered by alginate embedded magnetic nanoheaters: a combined therapy.
Topics: Alginates; Antibiotics, Antineoplastic; Breast Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Doxorubicin; Drug Carriers; Female; Ferric Compounds; Glucuronic Acid; Hexuronic Acids; Humans; Hyperthermia, Induced; Magnetics; Metal Nanoparticles; Temperature | 2011 |
Rose bengal-grafted biodegradable microcapsules: singlet-oxygen generation and cancer-cell incapacitation.
Topics: Alginates; Breast Neoplasms; Capsules; Chitosan; Drug Delivery Systems; Electron Spin Resonance Spectroscopy; Female; Glucuronic Acid; Hexuronic Acids; Humans; Microscopy, Confocal; Microscopy, Electron, Scanning; Nanotechnology; Rose Bengal; Singlet Oxygen; Spectrophotometry, Infrared | 2011 |
Rotary culture promotes the proliferation of MCF-7 cells encapsulated in three-dimensional collagen-alginate hydrogels via activation of the ERK1/2-MAPK pathway.
Topics: Alginates; Biomimetic Materials; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Collagen; Extracellular Matrix; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogels; MAP Kinase Signaling System; Materials Testing; Mechanotransduction, Cellular; Rotation; Tissue Engineering; Tissue Scaffolds | 2012 |
Lead optimization of a dihydropyrrolopyrimidine inhibitor against phosphoinositide 3-kinase (PI3K) to improve the phenol glucuronic acid conjugation.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Crystallography, X-Ray; Enzyme Activation; Female; Glucuronic Acid; Humans; Hydrogen Bonding; Inhibitory Concentration 50; Mice; Molecular Structure; Phenols; Phosphoinositide-3 Kinase Inhibitors; Pyrimidines; Pyrroles; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2013 |